3′,4′-Dihydroxyflavonol Attenuates Lipopolysaccharide-Induced Neuroinflammatory Responses of Microglial Cells by Suppressing AKT–mTOR and NF-κB Pathways
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b23-00033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Tatsuhiro Akaishi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University. Hauptthemen laut MEDLINE: Alzheimer Disease, NF-kappa B. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pharmacology, Faculty of Pharmacy and Research Institute of Pharmaceutical Sciences, Musashino University.
Zitieren
APA
Akaishi, T., Yamamoto, S., & Abe, K. (2023). 3′,4′-Dihydroxyflavonol Attenuates Lipopolysaccharide-Induced Neuroinflammatory Responses of Microglial Cells by Suppressing AKT–mTOR and NF-κB Pathways. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00033
Vancouver
Akaishi T, Yamamoto S, Abe K. 3′,4′-Dihydroxyflavonol Attenuates Lipopolysaccharide-Induced Neuroinflammatory Responses of Microglial Cells by Suppressing AKT–mTOR and NF-κB Pathways. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b23-00033
BibTeX
@article{Akaishi2023,
author = {Akaishi, Tatsuhiro and Yamamoto, Shohei and Abe, Kazuho},
title = {3′,4′-Dihydroxyflavonol Attenuates Lipopolysaccharide-Induced Neuroinflammatory Responses of Microglial Cells by Suppressing AKT–mTOR and NF-κB Pathways},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b23-00033}
}
EUVIMED